Davidson Kempner Capital Management LP : Form 8.3 - Allergan plc


Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION
Name of person dealing (Note 1) Davidson Kempner Capital Management LP
Company dealt in Allergan PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares
Date of dealing 2019-08-22
  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
  Long Short
  Number   (%) Number   (%)
(1) Relevant securities 4,016,996 1.2254    
(2) Derivatives (other than options)        
(3) Options and agreements to purchase/sell        
Total 4,016,996 1.2254    
  1. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
  Number   (%) Number   (%)
(1) Relevant securities    
 

(2) Derivatives (other than options)
   
 

(3) Options and agreements to purchase/sell
   
Total    


Ap20

  1. DEALINGS (Note 4)
  1. Purchases and sales
 

Purchase/sale
 

Number of relevant securities
 

Price per unit (Note 5)
Purchase 10,000 160.7884 USD
  1. Derivatives transactions (other than options transactions)
Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
       
  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
             
  1. Exercising
Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)
     
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)
     


Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            YES/NO

Date of disclosure 2019-08-23
Contact name James Gange
Telephone number 212 446 4029
If a connected EFM, name of offeree/offeror with which connected  
If a connected EFM, state nature of connection (Note 10)